PROFOUND MEDICAL CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.19 CAD | -2.78% |
|
+5.97% | +0.81% |
| 15/05 | Transcript : Profound Medical Corp. - Shareholder/Analyst Call | |
| 14/05 | Sector Update: Health Care Stocks Steady Premarket Tuesday | MT |
Presenter SpeechAdam Milligan (Executives)Before we kick off our program today, let us start b...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO is designed to provide customizable and predictable radiation-free ablation of a surgeon-defined prostate volume while protecting the urethra and rectum. TULSA-PRO has the potential to be a flexible technology in customizable prostate ablation, including intermediate stage cancer, localized radio-recurrent cancer, retention and hematuria palliation in locally advanced prostate cancer and the transition zone in large volume benign prostatic hyperplasia. It is also commercializing Sonalleve, which is a therapeutic platform for the treatment of uterine fibroids and palliative pain treatment of bone metastases.
Calendar
08/08/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
11.19
CAD
Average target price
12.5
CAD
Spread / Average Target
+11.71%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +0.81% | 207M | |
| +12.15% | 228B | |
| +14.90% | 196B | |
| +18.22% | 141B | |
| +29.13% | 110B | |
| +0.53% | 65.88B | |
| +16.90% | 54.3B | |
| +6.33% | 52.39B | |
| +10.93% | 45.22B | |
| +5.87% | 37.12B |
- Stock Market
- Equities
- PRN Stock
- News Profound Medical Corp.
- Transcript : Profound Medical Corp. - Analyst/Investor Day
